VAERS reports by lot

GSK Varicella/Shingles lot 2B3P2: VAERS reports

22 VAERS reports list lot 2B3P2 as a GSK Varicella/Shingles vaccine, received between 2019-12-15 and 2022-04-04. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1923%
Injection-site / Local reaction1721%
Neurological1519%
Dermatological (non-injection-site)1012%
Gastrointestinal79%
Musculoskeletal79%
Allergic / Anaphylactic45%
Respiratory11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania4
Ohio4
Texas2
Indiana1
Georgia1
Missouri1
Massachusetts1
Michigan1
Florida1
Colorado1
Vermont1
Kentucky1

Reports by month received

2019-123
2020-015
2020-023
2020-034
2020-041
2020-081
2020-101
2020-112
2021-061
2022-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.